Drug intelligence / Profile preview

paracetamol + amantadine hydrochloride

Development stage
Unknown
Lead developer
Harbin Taihua Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

**Paracetamol + amantadine hydrochloride** is a fixed-dose combination drug primarily used for symptomatic relief of common cold and influenza symptoms, including fever, headache, nasal congestion, rhinorrhea, sneezing, sore throat, and limb pain, as well as for influenza prevention and treatment. Paracetamol (acetaminophen) acts as an antipyretic and analgesic by inhibiting prostaglandin synthesis. Amantadine hydrochloride is an antiviral agent that inhibits influenza A virus replication by blocking the viral M2 ion channel and also has anticholinergic and dopaminergic effects that enhance analgesia and reduce symptoms. Formulations often include additional excipients like chlorphenamine maleate (antihistamine), caffeine (central stimulant to potentiate analgesia and counter sedation), and artificial Calculus Bovis (antipyretic and anticonvulsant). Developed in China, it is available as capsules (e.g., 0.377g, containing 250mg paracetamol and 100mg amantadine HCl) or tablets, administered orally.[1][3][5][9][10]

Brand names
Fufang Anfenwanan capsules
Other names
compound paracetamol and amantadine hydrochloride capsulescompound paracetamol and amantadine hydrochloride tabletsParacetamol and Amantadine Compound
02

Targets

CHRM2 (M2)DAT (Dopamine plasma membrane transport protein)COXNMDAR (Glutamate receptor ionotropic, NMDA)SIGMAR1 (Sigma non-opioid intracellular receptor 1)

Beyond the preview

Go deeper on paracetamol + amantadine hydrochloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on paracetamol + amantadine hydrochloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call